Mylan Sues Insys Over Attempt To Cut Off Distribution Deal

Law360, Washington (January 23, 2014, 3:22 PM EST) -- Mylan Pharmaceuticals Inc. on Tuesday sued Insys Therapeutics Inc. in Arizona federal court, alleging the drug developer had wrongly tried to end a distribution deal for anti-nausea drug dronabinol, citing a nonexistent dispute for the attempted contract termination.

Insys had signed an exclusive deal with Mylan in May 2011 to distribute the drug, but has twice “unjustifiably” attempted to end the contract between the companies without following the terms of the agreement, according to Mylan.

“In this most recent episode, Insys has fabricated a ‘dispute’ concerning...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.